Showing results (391-400 of 480) with videos related to
Sort By:
Pageof 48
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational StudyThomas Greuter, Anne Godat, Amit Ringel, et al.NEJM Evidence|September 23, 2025
Cendakimab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Christina M Charriez, Sandra Zhang, et al.Allergy|May 1, 2026
Molecular Characterization of Non-Specific Esophagitis Reveals a Distinct Non-Eosinophilic Phenotype With Fibrotic TraitsMarc Pfefferle, Darko Stojkov, Dagmar Simon, et al.Frontiers in Allergy|December 1, 2022
Immunologic and pathologic characterization of a novel swine biomedical research model for eosinophilic esophagitisLizette M Cortes, David Brodsky, Celine Chen, et al.Journal of Pediatric Gastroenterology and Nutrition|August 4, 2018
Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic EsophagitisElizabeth T Jensen, Kevin Z Huang, Hannah X Chen, et al.Alimentary Pharmacology & Therapeutics|December 16, 2024
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic OesophagitisAlfredo J Lucendo, Óscar Nantes-Castillejo, Alex Straumann, et al.Southern Medical Journal|June 5, 2018
Practice Pattern Variation in Pediatric Eosinophilic Esophagitis in the Carolinas EoE Collaborative: A Research Model in Community and Academic PracticesKevin Z Huang, Elizabeth T Jensen, Hannah X Chen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 13, 2014
Durability and predictors of successful radiofrequency ablation for Barrett's esophagusSarina Pasricha, William J Bulsiewicz, Kelly E Hathorn, et al.Gut|July 9, 2023
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trialEvan S Dellon, Kathryn A Peterson, Benjamin L Mitlyng, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2022
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert RecommendationsUlrike von Arnim, Luc Biedermann, Seema S Aceves, et al.Pageof 48